These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34589581)
1. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581 [TBL] [Abstract][Full Text] [Related]
2. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis. Cui Z; Wang Q; Deng MH; Han QL Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064 [TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling. Yang Y; Dong MH; Hu HM; Min QH; Xiao L Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964 [TBL] [Abstract][Full Text] [Related]
4. Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis. Gao Y; Xie M; Guo Y; Yang Q; Hu S; Li Z Front Genet; 2020; 11():715. PubMed ID: 32849774 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer. Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387 [TBL] [Abstract][Full Text] [Related]
6. LncRNA FGD5-AS1 reduces cardiomyocyte apoptosis and inflammation by modulating Akt and miR-223-3p expression. Zhao Y; Wang C; Cui T; Wang Q; Xu Y; Miao C; Liu S Am J Transl Res; 2022; 14(9):6175-6186. PubMed ID: 36247255 [TBL] [Abstract][Full Text] [Related]
7. lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes. Fang XL; Shi SG Hum Exp Toxicol; 2022; 41():9603271221138969. PubMed ID: 36445031 [TBL] [Abstract][Full Text] [Related]
8. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis. Li B; Yu X; Pang F Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1). Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e. Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer. Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170 [TBL] [Abstract][Full Text] [Related]
12. microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2. Chen W; Chen Y; Hui T J Chemother; 2023 Oct; 35(6):539-549. PubMed ID: 36546770 [TBL] [Abstract][Full Text] [Related]
13. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism. Ding Y; Gao S; Zheng J; Chen X Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254 [TBL] [Abstract][Full Text] [Related]
14. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis. Yang Y; Sun Z; Liu F; Bai Y; Wu F Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880 [TBL] [Abstract][Full Text] [Related]
15. FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis. Li J; Wu X; Shi Y; Zhao H J Orthop Surg Res; 2021 Nov; 16(1):665. PubMed ID: 34772438 [TBL] [Abstract][Full Text] [Related]
16. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis. Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727 [TBL] [Abstract][Full Text] [Related]
17. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751 [TBL] [Abstract][Full Text] [Related]
18. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis. Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway. Hu J; Huang L; Ding Q; Lv J; Chen Z Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120 [TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway. Chen H; Lan Z; Li Q; Li Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2098-2106. PubMed ID: 31144533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]